Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease | Zendy

Shenglan Yi | Zendy; Rui Chang | Zendy; Jianping Hu | Zendy; Yiguo Qiu | Zendy; Qingfeng Wang | Zendy; Qingfeng Cao | Zendy; Gangxiang Yuan | Zendy; Guannan Su | Zendy; Chunjiang Zhou | Zendy; Yao Wang | Zendy; Aize Kijlstra | Zendy; Peizeng Yang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease

Author(s) -

Shenglan Yi,

Rui Chang,

Jianping Hu,

Yiguo Qiu,

Qingfeng Wang,

Qingfeng Cao,

Gangxiang Yuan,

Guannan Su,

Chunjiang Zhou,

Yao Wang,

Aize Kijlstra,

Peizeng Yang

Publication year - 2018

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.18-24630

Subject(s) - cd86 , flow cytometry , biology , dendritic cell , immune system , autophagy , immunology , cancer research , microbiology and biotechnology , t cell , apoptosis , biochemistry

Recent studies reported that the tumor suppressor disabled-2 (DAB2) is a negative regulator of immune function. In this study, we investigated the role of DAB2 in monocyte-derived dendritic cells (DCs) from Vogt-Koyanagi-Harada disease (VKH) patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research